Researchers at Brown and MIT have discovered a way to increase the potency of ADEPs by up to 1,200 times.
A new class of molecules called acyldepsipeptides — ADEPs — may provide a new way to attack bacteria that have developed resistance to antibiotics.
As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones that are no longer effective. One promising new class of molecules called acyldepsipeptides — ADEPs — kills bacteria in a way that no marketed antibacterial drug does — by altering the pathway through which cells rid themselves of harmful proteins.
Now, researchers from Brown University and the Massachusetts Institute of Technology have shown that giving the ADEPs more backbone can dramatically increase their biological potency. By modifying the structure of the ADEPs in ways that make them more rigid, the team prepared new ADEP analogs that are up to 1,200 times more potent than the naturally occurring molecule.
A paper describing the research was released on-line by the Journal of the American Chemical Society.
“The work is significant because we have outlined and validated a strategy for the enhancing the potency of this promising class of antibacterial drug leads,” said Jason Sello, professor of chemistry at Brown and the paper’s senior author. “The molecules that we have synthesized are among the most potent antibacterial agents ever reported in the literature.”
ADEPs kill bacteria by a mechanism by that is distinct from all clinically available anti-bacterial drugs. They work by binding to a protein in bacterial cells that acts as a “cellular garbage disposal,” as Sello describes it. This barrel-shaped protein, called ClpP, breaks down proteins that are misfolded or damaged and could be harmful to the cell. However, when ClpP is bound by an ADEP, it’s no longer so selective about the proteins it degrades In essence, the binding by ADEP causes the garbage disposal to run amok and devour healthy proteins throughout the cell. For bacteria, a runaway ClpP is deadly.
ADEPs have been shown to kill bacteria that cause staph infections, some kinds of pneumonia, tuberculosis, and other types of infection in the lab. The molecules have also been reported to cure bacterial infections in mice and rats.
ADEPs were first discovered as naturally occurring compounds. Certain bacteria produce them for chemical defense. But for the last few years, scientists including Sello’s group have been making synthetic ADEP analogs, in the hope of identifying compounds with potential as new drugs.
One approach the researchers thought might work involves making the ADEP molecule more rigid. Compared to the ClpP molecule to which it binds, the ADEP molecule is a bit “floppy,” Sello said. “We often use the expression ‘lock and key’ to describe how a small molecule binds to a protein. One can imagine that it is easier to fit a rigid key into a lock rather than a floppy key. In the same sense, rigid molecules often bind to their protein targets more tightly.”
Sello and his team synthesized several new ADEP molecules. They swapped out certain amino acids in the naturally occurring molecule with ones they thought might increase the molecule’s rigidity. To find out if the new molecules were indeed more rigid, the team performed experiments that tested the strength of hydrogen bonds within the molecule. Stronger hydrogen bonds would indicate a more rigid molecule.
The researchers placed ADEP molecules in a solution rich in deuterium, a hydrogen atom that has an extra neutron. Over time, the deuterium atoms in the solution will swap places with the hydrogen atoms in the ADEP molecules. The deuterium swap happens more slowly, however, when hydrogen atoms are involved with strong bonds. So if the modified ADEPs exchanged deuterium more slowly, it would be an indication of strong bonds and a more rigid molecule.
The experiments showed that the modified ADEPs exchanged deuterium as much as 380 times more slowly than the natural molecule, a clear indication that the molecules were more rigid.
“It was exciting to see how rather simple modifications to the ADEP structure could affect their rigidity in such a profound manner,” said Daniel Carney, a graduate student in Sello’s group. “More importantly, the results were in line with our ADEP design principle. It is always rewarding when a sophisticated chemical theory can be applied and validated by laboratory experiments.”
To follow up on the prediction that the rigid ADEPs would bind ClpP more tightly, Robert Sauer and Karl Schmitz at MIT measured the capacity of the ADEP analogs and the parent compound to produce the “runaway garbage disposal” phenomenon in solutions containing the ClpP protein. The experiments showed that the modified ADEPs produced the effect at much lower concentrations, indicating a higher binding efficiency. The results implied that the modified molecules were about seven times better than the standard ones at binding to ClpP.
The final step was testing whether the rigid ADEPs were better at killing bacteria in a test tube. Those tests showed that, compared to published reports for standard ADEPs, the modified compounds were much more potent against three different dangerous bacteria — 32 times more potent against S. aureus, 600 times more potent against E. faecalis, and 1,200 times more potent against S. pneumoniae.
Sello was a bit surprised by the dramatic increase in ADEP potency compared to the much more modest improvement in ClpP binding.
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Are Antibiotics a Recipe for Obesity in Childhood?on January 22, 2020 at 10:29 am
WEDNESDAY, Jan. 22, 2020 (HealthDay News) -- Children who receive multiple antibiotic prescriptions early in life may be vulnerable to obesity, two new studies suggest. In one study, researchers found ...
- Lack of antibiotics in low income countries 'worsening superbugs threat'on January 21, 2020 at 5:00 am
Only three new treatments available in 10 or more poorer countries, report finds ...
- Removal of Antibiotics from Water by Polymer of Intrinsic Microporosity: Isotherms, Kinetics, Thermodynamics, and Adsorption Mechanismon January 21, 2020 at 3:01 am
Traces of antibiotics within domestic and industrial effluents have toxic impact on human health as well as surrounding flora and fauna. Potential increase in antibiotic resistance of microorganisms ...
- Antibiotics May Cause Yeast Infections - Here's Why and How to Prevent Iton January 18, 2020 at 4:19 pm
About one-quarter to one-third of women will get a yeast infection after taking antibiotics. The vagina always has low levels of yeast, but it's suggested that broad-spectrum antibiotics - those that ...
- Lack of new antibiotics threatens efforts to contain drug-resistant infectionson January 18, 2020 at 6:24 am
Fighting infections is a steeper problem than usual. That’s the upshot of the World Health Organization, which warns that diminishing financial investments and less innovation in the development of ...
- Big pharma failing to invest in new antibiotics, says WHOon January 17, 2020 at 3:00 pm
Big pharma continues to walk away from investment in new antibiotics and there are alarmingly few useful new drugs in the pipeline to deal with the worsening crisis of antibiotic resistance, according ...
- W.H.O. Warns That Pipeline for New Antibiotics Is Running Dryon January 17, 2020 at 1:27 pm
In two new reports, the global health agency says only government intervention can fix the broken market for new antimicrobial drugs. With the pipeline for new antibiotics slowing to a trickle and ...
- Streptovertimycins A–H, new fasamycin-type antibiotics produced by a soil-derived Streptomyces morookaense strainon January 16, 2020 at 9:13 pm
Proc Natl Acad Sci USA. 2011;108:12629–34. Feng Z, Chakraborty D, Dewell SB, Reddy BVB, Brady SF. Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid ...
- Animal Antibiotics Antimicrobials Market And Forecast Assumptions Through 2025on January 16, 2020 at 1:18 am
Market Overview: The global Animal Antibiotics and Antimicrobialsmarket was valued at USD 3.76billion in 2016 and is projected to reach USD 5.60billionby 2025, growing at a CAGR of 4.54% from 2017 to ...
- Antibiotics Market Latest Advancement And New Upcoming Trends To 2029on January 15, 2020 at 1:05 am
A recent market research analysis titled, Antibiotics Market offers insightful information to the clients escalating their basic leadership size explores distinct significant facets associated with ...
via Bing News